Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Curr Opin Microbiol. 2011 Oct 23;14(6):741–747. doi: 10.1016/j.mib.2011.09.016

Table 1.

This table summarizes the compounds discussed in this review that influence B. subtilis multicellularity. The data are meant to be representative and not comprehensive. For instance, the producing organisms listed are not the only ones capable of making these natural products, and the bioactivities are only those currently described. The references listed refer to papers discussing the effects of these compounds specifically on B. subtilis.

Molecule Producer(s) Structure Other bioactivies Effect on B. subtilis Ref
Nystatin Streptomyces noursei Macrolide polyene Antifungal Matrix-production [21]
Amphotericin Streptomyces nodosus Macrolide polyene Antifungal;
Antiprotozoan
Matrix-production [21]
Gramicidin Bacillus brevis Peptide Gram (+) Antibacterial Matrix-production [21]
Surfactin B. subtilis Lipopeptide Antibacterial;
Antiviral;
Antifungal;
Hemolytic
Matrix-production;
Tendril avoidance
during swarming
[21], [57]
Valinomycin Streptomyces species Peptide Antiviral Matrix-production [21]
cis-2-decenoic acid P. aeruginosa Short-chain fatty acid Biofilm diserpsal Biofilm dispersal [32]
D-amino acids B. subtilis;
Many bacteria
D-amino acids Cell wall peptidoglycan;
Protein modifications
Biofilm dispersal [33]
Muropeptides Many bacteria Peptidoglycan fragments Germination stimulation [37]
Staurosporine Streptomyces species Indolocarbazole Protein kinase inhibition Germination inhibition [37]
ComX B. subtilis Isoprenylated
decapeptide
Competence,
sporulation, and
surfactin indiuction;
Strain-specific
[30]
CSF B. subtilis;
Bacillus mojavensis
Pentapeptide Competence,
sporulation, and
surfactin induction;
Species-specific
[54]